Vanda Pharmaceuticals (VNDA) Q2 2025 Earnings

May 7Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.57
-0.41
-0.24
-0.08

Details

Expected EPS
-0.573333
Actual EPS
-0.5
Surprise EPS
0.07
Surprise Percent
+12.79%

Description

⁨Vanda Pharmaceuticals⁩ (⁦VNDA⁩) has reported earnings of ⁦-0.5⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts